When the COVID-19 pandemic hit in March 2020, we listened to the challenges and concerns of our clients. In response, we launched a comprehensive solution to ensure that their workplaces were COVID-19 safe.
Safeguard your workforce while maintaining productivity.
Our COVID-19 solution integrates guidelines from both the CDC and OSHA into an overall workplace surveillance and response plan to limit the possibility of workplace COVID-19 transmission among workers. Our COVID-19 solution integrates with your existing health and safety protocols.
Our team, led by pandemic response expert, Dr. William Lang, has created this program to keep your employees safe and healthy while ensuring maximum efficiency.
The Benefits of our COVID-19 Program
Lower risk of transmission among employees
Day-to-day operational stability
Reduced workforce downtime
Confident, more engaged workforce
Diminished COVID-related claims
Decreased risk of litigation
The positive impact of our pandemic safety program is clear.
of employees screened daily
managed potential exposures
man-days of work saved (so far!)
Cathy Engelbert, Commissioner, WNBA
“In order to pull off a successful WNBA season amid the COVID-19 pandemic where we had the entire league at a single location, we knew it would take a great medical partner to ensure that our priority of keeping all involved healthy and safe was not only met, but exceeded the expectations of multiple stakeholders (players, coaches, athletic trainers, team physicians, and team and league staff). The medical professionals from JobSiteCare, from the medical director, the sports medicine physicians and registered nurses on site, to round the clock consultation resources, including infectious disease specialists, put in countless hours, hard work and diligence to keep the WNBA family on site at IMG Academy healthy and safe. Whenever we needed them, 24/7, they were there to help us manage the complexities of the medical needs for an entire league during a highly competitive season. We could not have completed our successful season without their services and support, and we are so grateful to them for being true MVPs of the 2020 WNBA season.”
COVID-19 Blog & Updates
One of our greatest concerns over the past couple of months has been why the COVID rate in the UK has remained stubbornly high.
Cases in Europe and the US continue a downward trajectory, with cases in the US declining by nearly 12% over the last week.
The advisory committee on immunization practices and the CDC director weighed in on the final US government recommendations for vaccination.
It looks like much of the world is emerging from a summer of COVID and is now on the downward side of the epidemic curve.
Earlier this week, a formal internal advisory report from the US FDA said that the data did support boosters for the general population.
As of the middle of this week, new case rates are down in more than half of the United States and the overall rate is down approximately 5%.
Around the world, in most areas, the delta-driven increase in cases is driving an increase in vaccine acceptance.
The big news of the last week is that the first Covid vaccine from Pfizer and BioNTech has been fully approved in the United States.
The FDA authorized what is not a booster, but guidance that primary immunization for immunocompromised individuals should consist of 3 shots.
Subscribe to Our Newsletter